X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fresenius Kabi Onco. with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FRESENIUS KABI ONCO. vs J.B.CHEMICALS - Comparison Results

FRESENIUS KABI ONCO.    Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FRESENIUS KABI ONCO. J.B.CHEMICALS FRESENIUS KABI ONCO./
J.B.CHEMICALS
 
P/E (TTM) x 22.1 14.1 156.7% View Chart
P/BV x 3.1 2.2 139.4% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 FRESENIUS KABI ONCO.   J.B.CHEMICALS
EQUITY SHARE DATA
    FRESENIUS KABI ONCO.
Mar-13
J.B.CHEMICALS
Mar-16
FRESENIUS KABI ONCO./
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs176318 55.3%   
Low Rs79200 39.3%   
Sales per share (Unadj.) Rs37.7148.0 25.5%  
Earnings per share (Unadj.) Rs5.119.1 26.7%  
Cash flow per share (Unadj.) Rs6.723.9 28.1%  
Dividends per share (Unadj.) Rs00.50 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs42.5128.9 33.0%  
Shares outstanding (eoy) m158.2384.82 186.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.7 193.1%   
Avg P/E ratio x25.013.6 184.2%  
P/CF ratio (eoy) x18.910.8 175.1%  
Price / Book Value ratio x3.02.0 149.0%  
Dividend payout %02.6 0.0%   
Avg Mkt Cap Rs m20,13521,951 91.7%   
No. of employees `0001.22.7 42.1%   
Total wages/salary Rs m7031,841 38.2%   
Avg. sales/employee Rs Th5,176.24,590.9 112.8%   
Avg. wages/employee Rs Th610.4673.4 90.6%   
Avg. net profit/employee Rs Th699.6592.1 118.2%   
INCOME DATA
Net Sales Rs m5,96312,551 47.5%  
Other income Rs m18542 3.3%   
Total revenues Rs m5,98113,093 45.7%   
Gross profit Rs m1,4302,055 69.6%  
Depreciation Rs m258412 62.5%   
Interest Rs m-2696 -27.2%   
Profit before tax Rs m1,2162,088 58.2%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-680-   
Tax Rs m342469 72.9%   
Profit after tax Rs m8061,619 49.8%  
Gross profit margin %24.016.4 146.5%  
Effective tax rate %28.122.5 125.3%   
Net profit margin %13.512.9 104.8%  
BALANCE SHEET DATA
Current assets Rs m5,1027,778 65.6%   
Current liabilities Rs m2,3854,358 54.7%   
Net working cap to sales %45.627.2 167.2%  
Current ratio x2.11.8 119.8%  
Inventory Days Days15055 274.4%  
Debtors Days Days11380 141.6%  
Net fixed assets Rs m5,1485,713 90.1%   
Share capital Rs m158170 93.3%   
"Free" reserves Rs m6,55610,547 62.2%   
Net worth Rs m6,73210,937 61.5%   
Long term debt Rs m9520-   
Total assets Rs m10,38815,574 66.7%  
Interest coverage x-45.822.8 -200.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.60.8 71.2%   
Return on assets %7.511.0 68.2%  
Return on equity %12.014.8 80.9%  
Return on capital %14.620.0 73.1%  
Exports to sales %74.548.7 152.9%   
Imports to sales %24.87.1 349.9%   
Exports (fob) Rs m4,4416,115 72.6%   
Imports (cif) Rs m1,477889 166.2%   
Fx inflow Rs m5,2986,169 85.9%   
Fx outflow Rs m1,7721,285 137.9%   
Net fx Rs m3,5254,884 72.2%   
CASH FLOW
From Operations Rs m1,2741,397 91.2%  
From Investments Rs m-1,204-320 376.0%  
From Financial Activity Rs m-196-1,196 16.4%  
Net Cashflow Rs m-126-102 123.5%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 81.0 0.3 27,000.0%  
Indian inst/Mut Fund % 0.3 3.4 8.8%  
FIIs % 9.6 3.9 246.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 9.1 37.0 24.6%  
Shareholders   42,599 30,437 140.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FRESENIUS KABI ONCO. With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare FRESENIUS KABI ONCO. With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FRESENIUS KABI ONCO. SHARE PRICE


Jan 2, 2014 (Close)

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. - SUVEN LIFE COMPARISON

COMPARE FRESENIUS KABI ONCO. WITH

MARKET STATS